Effect of creatine phosphate administration on the rat heart adenylate pool

Area of Science:

• Biochemistry
• Cardiology
• Pharmacology

Background:

• Creatine phosphate (CP) exhibits pharmacological properties, including improved myocardial protection in cardioplegic solutions.
• Exogenous CP demonstrates anti-arrhythmic effects and reduces lactate formation post-hemorrhagic shock, potentially by conserving adenosine triphosphate (ATP) stores.
• Previous research indicated elevated rat heart ATP and CP levels after intravenous CP administration.

Purpose of the Study:

• To investigate whether increased ATP levels following CP administration result from a rise in the total adenylate pool, energy charge, or both.
• To determine if elevated CP concentrations are due to changes in the CP/creatine ratio or an increase in the total creatine plus CP pool.

Main Methods:

• Intravenous administration of creatine phosphate to experimental animals.
• Measurement of myocardial adenine nucleotide levels, including ATP, adenylate pool, and energy charge.
• Analysis of creatine and creatine phosphate concentrations in heart tissue.

Main Results:

• Creatine phosphate administration significantly increased both the total adenylate pool and the energy charge in rat hearts.
• The study observed an increase in both creatine and creatine phosphate pools.
• These findings support the hypothesis that exogenous CP enhances myocardial energy metabolism.

Conclusions:

• Intravenous creatine phosphate administration effectively increases myocardial ATP levels by raising the adenylate pool and energy charge.
• CP administration also expands the total creatine plus CP pool, contributing to enhanced energy reserves.
• These results highlight the potential of creatine phosphate as a therapeutic agent for conditions involving energy depletion in the heart.